Torbay Pharmaceuticals opens new £26 million pharmaceutical manufacturing unit
The new facilities enable to company to further grow and flourish.
Torbay Pharmaceuticals, part of Torbay and South Devon NHS Foundation Trust, has officially opened its new manufacturing unit in Paignton.
The Trust’s Chairman (Sir Richard Ibbotson), Managing Director (Emma Rooth), Technical Director (Mark Andrews), together with staff and other partners, marked the milestone with a celebratory opening ceremony with Sir Richard unveiling a commemorative plaque.
Sir Richard Ibbotson, Chairman of Torbay and South Devon NHS Foundation Trust, said: “We are incredibly proud of Torbay Pharmaceuticals and all that they have achieved over the years. Not only have they created a range of highly skilled career opportunities, but they generate income which directly supports the health and care of local people. This is a first-rate example of what innovation in the NHS can contribute to local communities.
“These fabulous new facilities offer a modern, class-leading environment which will enable Torbay Pharmaceuticals to further grow and flourish. I, on behalf of the Trust Board, cannot thank everyone enough for their hard work in seeing this superb project come to fruition.”
Emma Rooth, Managing Director of Torbay Pharmaceuticals, said: “Torbay Pharmaceuticals is proud to be such a successful part of Torbay and South Devon NHS Foundation Trust. Being part of the NHS enables us to have our finger on the pulse of healthcare needs and respond appropriately with new products, plugging shortages and anticipating the latest developments in medical science.
“Since the establishment of the original pharmaceutical department at Torbay Hospital back in the 1970s, we have grown from strength to strength to meet not only our local population’s needs, but also the needs of the wider NHS and healthcare providers globally.
“The official opening of our new class-leading sterile product facility is a very exciting time for Torbay Pharmaceuticals. By strengthening our production capabilities and ensuring the delivery of high-quality products for our patients through this investment, we have created the platform upon which we can achieve significant growth for the organisation, its people and the region.”
Bryan Taylor, UK Property Director for Balfour Beatty, said: “The official opening of Torbay Pharmaceuticals new manufacturing unit in Paignton marks the completion of 8 years of involvement by Balfour Beatty. Having secured the plot, designed, developed and constructed the facility, the project reflects the all-encompassing skills, expertise and capabilities of Balfour Beatty in providing clients with whole project life cycle solutions.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance